It was found that miR-328 could target CD44, and they showed a negative regulatory relationship between them, which indicated that detecting the expression level of miR-328 can be used as a means to predict the prognosis of gastric cancer patients [27]. This evidence concerns the gene CD44 and gastric cancer.